Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
08/2005
08/24/2005EP1565446A1 Chk-, pdk- and akt-inhibitory pyrimidines, their production and use as pharmaceutical agents
08/24/2005EP1565436A2 3-aminopyrrolidine derivatives as modulators of chemokine receptors
08/24/2005EP1370558B1 Piperazine- and piperidine-derivatives as melanocortin receptor agonists
08/24/2005EP1353912B1 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof
08/24/2005EP1334085B1 Sulfamides as gamma-secretase inhibitors
08/24/2005EP1292190B1 N-phenyl-4-(4-pyridyl)-2-pyrimidineamine derivatives
08/24/2005EP1286975B1 Biclyclic cyclohexylamines and their use as nmda receptor antagonists
08/24/2005EP1214304B1 Benzylidene-thiazolidinediones and analogues and their use in the treatment of diabetes
08/24/2005EP1158980B1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
08/24/2005EP1124804B1 Prostaglandin endoperoxide h synthase biosynthesis inhibitors
08/24/2005EP1019075B1 Beta 2-adrenergic receptor agonists
08/24/2005CN1659165A Quinolinone derivatives
08/24/2005CN1659164A Benzoxazinone-derived compounds, their preparation and use as medicaments
08/24/2005CN1659162A Tricyclic thrombin receptor antagonists
08/24/2005CN1659161A Piperidine derivatives having CCR3 antagonism
08/24/2005CN1659153A PNA monomer and precursor
08/24/2005CN1659151A 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
08/24/2005CN1659145A 3-cyanoquinolines as inhibitors of EGF-R and HER2 kinases
08/24/2005CN1659143A Nitrogen-containing heteroaryl compounds having HIV integrase inhibitory activity
08/24/2005CN1658904A Combinations comprising epothilones and pharmaceutical uses thereof
08/24/2005CN1658875A 1-(4-piperidinyl) benzimidazolones as histamine H3 antagonists
08/24/2005CN1658874A (1-4-piperidinyl) benzimidazole derivatives useful as histamine H3 antagonists
08/24/2005CN1658871A Amide derivatives as GK activators
08/24/2005CN1658847A Use of EP4 receptor ligands in the treatment of IL-6 involved diseases
08/24/2005CN1658724A Luminescent element material and luminescent element comprising the same
08/24/2005CN1657524A Substituted azole compounds and their preparation and application
08/24/2005CN1657523A Cyclic compounds
08/24/2005CN1216056C Sulfamato hydroxamic acid metalloprotease inhibitor
08/24/2005CN1215835C Ketone derivatives and medical use thereof
08/23/2005US6933322 Substituted naphthylenes for the treatment of non-insulin dependent diabetes mellitus
08/23/2005US6933308 Aminoalkyl thiazole derivatives as KCNQ modulators
08/23/2005US6933304 Antitumor agents, osteoporosis
08/23/2005US6933299 Anilinoquinazolines as protein tyrosine kinase inhibitors
08/23/2005US6933261 2,4,5-Trisubstituted phenylketoenols
08/18/2005WO2005075600A1 Organic element for electroluminescent devices
08/18/2005WO2005075574A1 Neutral and cationic naphthalene derivatives and dyes containing said compounds for dyeing keratin fibers
08/18/2005WO2005075480A1 Diaza- or thiazadione derivatives with neuroprotective activity
08/18/2005WO2005075471A2 Thiazol-compounds as 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors
08/18/2005WO2005075470A1 Thiazole compounds
08/18/2005WO2005075469A1 Thiazolyl-hydroxamic acids and thiadiazolyl-hydroxamic acids, and use thereof for treating diseases associated with histone deacetylase enzymatic activity
08/18/2005WO2005075468A2 Pyridinyl - or pyrimidinyl thiazoles with protein kinase inhibiting activity
08/18/2005WO2005075436A2 Novel inhibitors of glutaminyl cyclase
08/18/2005WO2005075435A1 Modulators of atp-binding cassette transporters
08/18/2005WO2005075429A1 Novel quinoline-carbaxamides as jack3 kinase modulators
08/18/2005WO2005075426A1 Novel dipeptidyl peptidase iv inhibitors; processes for their preparation and compositions thereof
08/18/2005WO2005075424A1 New pyridin-2-one compounds useful as inhibitors of thrombin
08/18/2005WO2005074934A1 Thiazolylimidazole derivatives and their use as inhibitors of microsmal triglyce ride transfer protein
08/18/2005WO2005074642A2 Chemical compounds
08/18/2005WO2005063742A3 Amidino compounds as cysteine protease inhibitors
08/18/2005WO2004069197A3 Novel substituted 2,3-benzodiazepine derivatives
08/18/2005WO2004062361A3 Spiro compounds
08/18/2005WO2004060890A8 2-oxopyridin-3-yl thia (di) azole derivates for use in the treatment of cell proliferation and apoptosis related diseases
08/18/2005US20050182116 Such as 5-amino-3-[[4-(aminosulfonyl)phenyl]amino]-N-(2,6-difluorophenyl)-1H-1,2,4-triazole-1-carbothioamide, used as cyclin dependent and tyrosine kinase inhibitors, for prophylaxis of tumors
08/18/2005US20050182111 Alkenyl-substituted spirocyclic sulfamides as inhibitors of gamma-secretase
08/18/2005US20050182110 tetracylic bridged ring compounds such as 9-nitro-11-amino-11-((imidazol-2-yl)aminocarbonyl)-9,10-dihydro-9,10-ethanoanthracene; treating obesity, diabetes and inflammatory or immune associated diseases; nuclear factor kappa beta (NF-KB)
08/18/2005US20050182109 Heteroaryl substituted spriocyclic sulfamides for inhibition of gamma secretase
08/18/2005US20050182104 E.g., Methyl 2-[2-[2-(3,5-difluorophenyl)acetyl-amino]propanoylamino]-5-propylthiazole-4-carboxylate; beta -amyloid peptide inhibitors; used to treat senile dementia, Alzheimer's disease, Down's syndrome, Parkinson's disease, amyloid angiopathy and/or cerebrovascular disorders
08/18/2005US20050182082 Modulators of the glucocorticoid receptor, AP-1, and/or NF-kB activity and use thereof
08/18/2005US20050182072 Paget's disease; muscular disorders; cardiovascular disorders; antiinflamamtory agents; antidiabetic agents; autoimmune disease; leukemia
08/18/2005US20050182067 Vanilloid receptor ligands and their use in treatments
08/18/2005US20050182050 Therapeutic heterocyclic compounds
08/18/2005DE102004004787A1 New effector-linker and effector-recognition unit conjugates derived from epothilones, useful as targeted drugs for treating proliferative diseases, e.g. tumors or neurodegenerative disease
08/18/2005CA2555308A1 Thiazolylimidazole derivatives and their use as inhibitors of microsomal triglyceride transfer protein
08/18/2005CA2554809A1 Novel n-alkyl thiourea-and thioamide-substituted imidazolyl inhibitors and glutaminyl cyclase
08/18/2005CA2554796A1 Modulators of atp-binding cassette transporters
08/18/2005CA2554329A1 Pyridinyl - or pyrimidinyl thiazoles with protein kinase inhibiting activity
08/18/2005CA2554217A1 Diaza- or thiazadione derivatives with neuroprotective activity
08/18/2005CA2553604A1 New pyridin-2-one compounds useful as inhibitors of thrombin
08/17/2005EP1564217A2 Process for the production of epothilones
08/17/2005EP1564210A1 4-oxoquinoline compounds and utilization thereof as hiv integrase inhibitors
08/17/2005EP1562979A2 Tubulysins, method for producing the same and tubulysin preparations
08/17/2005EP1562941A2 Trans-9,10-dehydroepothilone c and d, analogs thereof and methos of making the same
08/17/2005EP1562937A2 N-substituted piperidine derivatives as serotonin receptor agents
08/17/2005EP1562936A2 Therapeutic piperazine compounds
08/17/2005EP1562933A2 Substituted amine derivatives and methods of use in the treatment of angiogenesis related disorders
08/17/2005EP1562928A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors
08/17/2005EP1562925A1 Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
08/17/2005EP1562920A1 Antiinflammatory 3-arylthio-3-thiazolyl-alkylamines
08/17/2005EP1562919A1 Phenylalkyl and pyridylalkyl piperazine derivatives
08/17/2005EP1562915A1 Farnesoid x receptor agonists
08/17/2005EP1562898A1 Indole derivatives as somatostatin agonists or antagonists
08/17/2005EP1562895A1 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
08/17/2005EP1562595A1 Diaryl ethers as opioid receptor antagonists
08/17/2005EP1562589A2 Diaminotriazoles useful as inhibitors of protein kinases
08/17/2005EP1499594B1 Process for the preparation of 7-substituted-3-quinoline and 3-quinol-4-one carbonitriles
08/17/2005EP1343761B1 Piperidine mch antagonists and their use in the treatment of obesity
08/17/2005EP1340750B1 Amide derivatives
08/17/2005EP1266887B1 Indenoindoline derivatives, their process of preparation and pharmaceutical compositions containing them
08/17/2005EP1265893B1 Hydrochloride salts of 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione
08/17/2005EP1161240B1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
08/17/2005CN1656092A Robertson Graeme Michael et al.
08/17/2005CN1656087A Therapeutic ion channel blocking agents and methods of use thereof
08/17/2005CN1656083A Novel heterocyclic compounds having antibacterial activity; process for their preparation and pharmaceutical compositions containing them
08/17/2005CN1656077A Process for preparing chiral diol sulfones and dihydroxy acid HMG CoA reductase inhibitors
08/17/2005CN1656071A New piperidine derivative
08/17/2005CN1655785A N-acyl piperidine derivatives for use as melanocortin receptor ligands in the treatment of feeding disorders
08/17/2005CN1655780A Thiazolidine carboxamide derivatives as modulators of the prostaglandin f receptor
08/17/2005CN1655779A Substituted benzazoles and methods of their use as inhibitors of Raf kinase
08/17/2005CN1654460A Continuous process for the preparation of pesticidal chlorothiazoles
08/17/2005CN1215110C Pyrimidine derivs. as hardness stabilizers
1 ... 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 ... 628